Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$3.99
-8.90%
(-0.39) 1D
$4.12
+3.26% (+0.13)
Pre-market
Closed: May 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ORMP...
Open
$4.40
High
$4.40
Low
$3.98
Mkt. cap
163.30M
Avg. vol.
171.52K
Volume
483.00
P/E ratio
1.53
52-wk high
$5.01
52-wk low
$1.98
EPS
$2.60
Beta
1.27
Shares outstanding
40.93M
No. of employees
13
News stories
From sources across the web
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.
CEONadav Kidron
Employees13
Founded2006
Headquarters-
SectorPharmaceutical industry
Websiteoramed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.03M
1.15M
1.99M
1.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.46M
1.27M
3.68M
2.06M
Operating expense
2.49M
2.43M
5.67M
3.66M
Total operating expenses
2.49M
2.43M
5.67M
3.66M
Operating income
-2.49M
-2.43M
-5.67M
-3.66M
Other non operating income
257.00K
408.00K
-313.00K
8.15M
EBT including unusual items
13.13M
59.45M
9.80M
49.44M
EBT excluding unusual items
-1.54M
-1.51M
-5.90M
4.72M
Income tax expense
-126.00K
11.06M
-212.00K
11.13M
Effective tax rate
-0.96%
18.61%
-2.16%
22.51%
Other operating expenses
-
-
-
-
Net income
13.29M
48.40M
10.01M
38.31M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
689.00K
509.00K
337.00K
276.00K
Interest expense
-
-
-
-
Net interest expenses
689.00K
509.00K
337.00K
276.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.46M
-2.40M
-5.64M
-3.63M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer